Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

A new system involving heart failure nurses at a Norfolk hospital has seen device alert response times plummet from weeks to ...

Bayer announced the FDA approved finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, for the ...

It’s as if sudden cardiac arrest is met with a resigned shrug: If it’s nearly impossible to predict and even harder to treat, ...

Approval of Kerendia was based on results from the Phase III FINEARTS-HF trial, which demonstrated statistically significant ...

The study found that heart attack-related deaths decreased by almost 90% between 1970 and 2022. Specifically, heart disease accounted for 41% of deaths in 1970, and as of 2022, that number declined to ...

Cardiologist Dr. Bimal Chhajer shares 10 heart-friendly foods that help lower cholesterol, control blood pressure, and fight ...